See results from clinical trials with Trulicity when assessed for A1C reduction, weight change and CV risk reduction.
Change from baseline in systolic blood pressure at Week 40/42. Data are
PDF) Diabetes treatment intensification and associated changes in HbA1c and body mass index: A cohort study
Cureus, Tirzepatide: A Promising Drug for Type 2 Diabetes and Beyond
Randomized Trial of Empagliflozin in Nondiabetic Patients With Heart Failure and Reduced Ejection Fraction
Diabetes Canada Clinical Practice Guidelines
DECLARE-TIMI 58 – TIMI STUDY GROUP
Clinical Trials: Lowereing A1C, Weight Change & CV Data, HCP
Applying Recent A1C Recommendations in Clinical Practice
A Review of the Glycemia Reduction Approaches in Diabetes (GRADE) Study: Comparing the Effectiveness of Type 2 Diabetes Medications
Frontiers Durability of glucose-lowering effect of dulaglutide in patients with type 2 diabetes mellitus: A real-world data study
The Biggest News in Diabetes Technology, Drugs, and Nutrition: Highlights from ADA 2020
A randomized clinical trial comparing low-fat with precision nutrition–based diets for weight loss: impact on glycemic variability and HbA1c - The American Journal of Clinical Nutrition
Clinical Trials: Lowereing A1C, Weight Change & CV Data, HCP
Comparing the Effects of Consuming Almonds or Biscuits on Body Weight in Habitual Snackers: A 1-Year Randomized Controlled Trial - The American Journal of Clinical Nutrition
